The antimicrobial-coated medical devices market size is projected to be valued at USD 1,485.0 million in 2023 and is expected to rise to USD 5,123.5 million by 2033. The sales of antimicrobial-coated medical devices are expected to register a significant CAGR of 13.2% during the forecast period.
Growth is attributed to the rising awareness about bacterial and microbial infections. From 2018 to 2022, the market experienced a CAGR of 8.9%. The antimicrobial coating is useful in healthcare-associated infections. The antimicrobial coating features a highly effective viable antimicrobial coating and modifications precisely dosed and delivered right from the surface of the medical device.
Antimicrobial coating targets the reduction of accumulation on biomedical devices through changing interfacial characteristics.
The increasing awareness about bacterial and microbial infections led to the rising demand for antimicrobial-coated medical devices is expected to provide growth opportunities for the market.
North America is considered a highly lucrative market for the antimicrobial-coated medical devices market, driven primarily by its utilization across the healthcare sector and rapid infrastructure development in healthcare.
The high cost of the coating process and stringent rules and regulations restrict the demand for antimicrobial coating and restrain the growth of the global antimicrobial-coated medical devices market over the forecast period.
Attribute | Details |
---|---|
Market Estimated Size (2023) | USD 1,485 million |
Market CAGR (2023 to 2033) | 13.2% |
Devices Market Forecasted Size (2033) | USD 5,123.5 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Technological advancement in the healthcare sector and the increasing burden of cardiovascular diseases are expected to accrue significant benefits to the global antimicrobial-coated medical devices market. Also, technological advancements in antimicrobial coatings and the growing implantable devices market are expected to propel the growth of the antimicrobial-coated medical devices market in forecasting years.
The increasing research and development activities and innovations in the antimicrobial coating process are also expected to bolster the growth of the global antimicrobial-coated medical devices market. The advanced medical infrastructure and facilities are also expected to propel the demand for antimicrobial-coated medical devices, driving the global market over a forecast period.
Although the antimicrobial-coated medical devices market has numerous uses, numerous obstacles likely pose a challenge to market growth. High costs associated with a coating process and other components may hamper the growth of the global antimicrobial-coated medical devices market.
In addition, the stringent rules and regulations and unfavorable reforms for the material and process used for antimicrobial coating for medical devices may hinder the growth of the antimicrobial-coated medical devices market in the forecasting period. The limitations related to metallic coatings, such as silver coating and copper coating, due to antimicrobial resistance, may restrain the growth of the global antimicrobial-coated medical devices market over the forecast period.
These catheters are specially designed with coatings that help inhibit the growth of bacteria and reduce the risk of catheter-associated infections.
Antimicrobial-coated catheters have become increasingly important due to the high prevalence of catheter-related infections and associated healthcare complications. Antimicrobial coatings on catheters act as a protective barrier, preventing the colonization of microorganisms on the catheter surface and reducing the likelihood of infection transmission.
The antimicrobial-coated catheters market encompasses a wide range of catheter types, including urinary catheters, central venous catheters, peripheral intravenous catheters, and arterial catheters. These catheters are used in various healthcare settings, such as hospitals, clinics, and home care, to provide essential medical interventions.
These devices are equipped with metallic coatings, such as silver, copper, or zinc, which possess inherent antimicrobial properties. The use of metallic coatings on catheters has gained traction due to their effectiveness in inhibiting the growth of bacteria and reducing the risk of infections. Metallic antimicrobial-coated catheters find extensive application in various medical settings, including urinary catheters and central venous catheters.
The durable antimicrobial activity of these coatings provides prolonged protection against microbial colonization, making them a preferred choice for healthcare providers aiming to enhance patient safety and minimize catheter-associated infections. As the awareness of infection control continues to increase, the demand for metallic antimicrobial-coated catheters is expected to grow, contributing to the overall expansion of the antimicrobial-coated catheters market.
North America is the leading market for the angiographic-catheters market. It is expected to continue into the forecast period owing to the increasing preference for advanced antimicrobial-coated medical devices over conventional procedures for patient safety purposes.
Rising awareness about antimicrobial-coated medical devices and increasing government investment in medical technologies are the other factors fueling the growth of this market in the region.
The region is forecast to have a 36.2% market share of the antimicrobial-coated medical devices market. North America is expected to be the next dominant region witnessing high adoption rates for the antimicrobial-coated medical devices market during the forecast period.
According to Future Market Insights, Europe is expected to provide immense growth opportunities for the antimicrobial-coated medical devices market due to the expansion of the healthcare sector in the region. The antimicrobial-coated medical devices market is expected to witness sustained growth over the forecast period.
The growth of the antimicrobial-coated medical devices market is driven by the increasing demand for antimicrobial-coated medical devices in the region. Europe accounts for a total of 27.8% share in the antimicrobial-coated medical devices market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is highly competitive due to the presence of several leading participants. While global players such as AST Products, Inc., Covalon Technologies Ltd., and BASF SE account for a considerable market size, several regional-level players are also operating across key growth regions.
Recent Developments :
Innovative antimicrobial coating technology was on display, including BioCote Limited's most recent advancements for plastic antimicrobial coating solutions. This increased the business's yearly revenue.
The company Hydromer has announced that Avinger, Inc. has chosen them as a significant partner for coating and services. This action aids the business in accelerating its market expansion.
Attribute | Details |
---|---|
Growth Rate | CAGR of 13.2% from 2023 to 2033 |
Base Year of Estimation | 2023 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in USD million and Volume in Units and F-CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
Key Segments Covered | Device Type, Coating Material, By Region |
Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
Key Companies Profiled | AST Products Inc.; Covalon Technologies Ltd.; BASF SE; Bio Interaction Ltd.; Royal DSM; Sciessent LLC; Specialty Coating Systems Inc.; Hydromer Inc.; Dow Chemical Company; Biocote; PPG Industries, Inc. |
Customization & Pricing | Available upon Request |
The market is valued at USD 1,485.0 million in 2023.
The market is estimated to secure a valuation of USD 5,123.5 million in 2033.
Through 2033, the market is projected to continue to expand at a CAGR of 13.2%.
Antimicrobial-coated catheters possess 37.20% of the antimicrobial-coated catheters market.
Europe retains a market share of 27.8%.
The market grew at an HCAGR of 8.9% from 2018 to 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device Type 5.1. Catheters 5.2. Surgical Instruments 5.3. Implantable Devices 5.4. Coated Devices 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Coating Material 6.1. Metallic 6.1.1. Silver Coating 6.1.2. Copper Coating 6.1.3. Other Metal Coatings 6.2. Non-Metallic 6.2.1. Polymeric Coating 6.2.2. Organic Coating 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. AST Products Inc. 17.2. Covalon Technologies Ltd. 17.3. BASF SE 17.4. Bio Interaction Ltd. 17.5. Royal DSM 17.6. Sciessent LLC 17.7. Specialty Coating Systems Inc. 17.8. Hydromer Inc. 17.9. Dow Chemical Company 17.10. Biocote 17.11. PPG Industries, Inc. 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports